Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CCAAT/enhancer binding proteins and interferon signaling pathways.

Dhananjaya V Kalvakolanu1, Sanjit K Roy

  • 1Greenebaum Cancer Center, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. dkalvako@umaryland.edu

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|December 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIF1α mediates resistance to radiation and to KRAS inhibitors in pancreatic adenocarcinoma.

PloS one·2026
Same author

Regulation of Autophagy and Metabolism in Hepatocellular Carcinoma: Involvement of Wnt-β-Catenin Pathway.

Journal of cellular and molecular medicine·2026
Same author

Calcium Phosphate-Induced Injury in Kidney Tubular Cells-Supersaturated Solution vs Preformed Crystals.

Journal of biochemical and molecular toxicology·2025
Same author

Publisher's Note: Identification and characterization of GRIM-1, a cell-death-associated gene product.

Journal of cell science·2024
Same author

Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma.

Journal of cellular and molecular medicine·2024
Same author

Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1.

International journal of radiation biology·2023

Interferons (IFNs) control immune responses through IFN-stimulated genes (ISGs). This study reveals how IFN-gamma-induced MAPK pathways regulate the transcription factor C/EBP-beta, impacting host defense mechanisms.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Interferons (IFNs) are critical cytokines that orchestrate innate and adaptive immunity.
  • Host responses to IFNs rely on the expression of IFN-stimulated genes (ISGs).
  • Complex regulatory mechanisms are necessary to control diverse IFN-induced responses.

Purpose of the Study:

  • To elucidate a novel pathway controlling transcription factor C/EBP-beta activity.
  • To investigate the role of IFN-gamma-induced MAPK signaling in regulating C/EBP-beta.
  • To understand how C/EBP-beta controls IFN-stimulated gene expression.

Main Methods:

  • Analysis of IFN-gamma-induced MAPK signaling pathways.
  • Investigating the phosphorylation and dephosphorylation of C/EBP-beta.

Related Experiment Videos

  • Assessing the recruitment of transcriptional coactivators to C/EBP-beta.

    • Main Results:

    • Identified convergence of two IFN-gamma-induced MAPK pathways on C/EBP-beta.
    • Demonstrated that extracellular signal-regulated kinases (ERKs) phosphorylate C/EBP-beta.
    • Showed that mixed-lineage kinases (MLKs) induce dephosphorylation, facilitating coactivator recruitment.

    Conclusions:

    • IFN-gamma-induced MAPK signaling pathways play a crucial role in regulating C/EBP-beta.
    • Dual phosphorylation events mediated by ERKs and MLKs fine-tune C/EBP-beta's transcriptional activity.
    • This regulatory mechanism provides insights into the control of ISG expression and immune responses.